Seasonal in Biological Technology

Novavax Reports Second Quarter 2009 Financial Results

... an initial agreement to license the company's seasonal and Pandemic Influenza VLP technology to ROVI to ... II trial in healthy adults with our trivalent seasonal flu vaccine candidate; Initiate a Phase II clinical study of our trivalent seasonal flu vaccine in older adults; Continue ...

Sanofi-aventis Announces Second Quarter 2009 Results

... 83 million for the quarter. Net sales of seasonal influenza vaccines rose by 3.3% to euro 32 ... United States to 150 million doses of trivalent seasonal influenza vaccine per year. Sanofi Pasteur ... ------- ---- -------- * seasonal and pandemic influenza vaccines **+3.3% for ...

FluMist(R) Begins Shipping for 2009-2010 Influenza Season

... announced today that it has begun shipping its seasonal influenza vaccine FluMist((R) )(Influenza Vaccine ... "MedImmune is committed to delivering our seasonal nasal spray influenza vaccine in the summer ... more eligible children can be vaccinated against seasonal influenza while attending back-to-school ...

Cadila Pharmaceuticals Launches Joint Venture With Novavax in India

... and develop, produce and sell products such as seasonal influenza vaccine and potentially other novel ... conducting Phase 2 clinical studies of a seasonal flu vaccine and recently announced a research ... strain. The company also plans to initiate a seasonal flu vaccine study in elderly subjects later this ...

Spanish Government Selects Novavax's VLP Technology for Comprehensive Flu Vaccine Solution in Spain

... other government groups to develop pandemic and seasonal flu vaccines and establish its only in-border ... ROVI Pharmaceuticals to help develop pandemic and seasonal flu vaccine solutions for Spain, the world's ... conducting Phase II clinical studies of a seasonal flu vaccine and recently announced a research ...

Preclinical Proof-of-Concept Studies Published for Novavax Seasonal Influenza Virus-Like-Particle Vaccine

... Protective Immune Responses against a Variety of seasonal Influenza Strains in Mice and Ferrets ... T cell responses in mice vaccinated with the seasonal VLP vaccine were compared with T cell responses ... which supported the human clinical trials of our seasonal influenza VLP vaccine," said Dr. Rahul Singhvi, ...

HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A (H1N1)

... MedImmune Plans to Begin Shipping seasonal Vaccine to Health Care Providers in August ... regulatory approval can be obtained. seasonal FluMist (R) on Track to Begin Shipping in ... to help protect all eligible age groups against seasonal influenza is to vaccinate prior to and during the ...

Novavax Reports First Quarter 2009 Financial Results

... in the second Phase II study of its trivalent seasonal influenza VLP vaccine candidate. This clinical ... II trial in healthy adults with our trivalent seasonal flu vaccine candidate; Preclinical ... of a Phase II clinical study of our trivalent seasonal flu vaccine in older adults. ...

Novavax Announces Enrollment in the Second Phase II Study of its Seasonal Influenza VLP Vaccine Candidate

... Development of the seasonal influenza virus-like particle (VLP) vaccine ... clinical trial of its virus-like particle (VLP) seasonal influenza vaccine. Building on data from the ... III efficacy study. Specifically, the trivalent seasonal vaccine containing VLPs against the 2008-2009 ...

Schering-Plough Announces Collaboration With World Health Organization to Provide Access to Pandemic Influenza Vaccine Technology to Developing Countries

... to develop, register, manufacture, use and sell seasonal and pandemic live, attenuated, influenza vaccines ... is developing a cell culture-based LAIV for seasonal influenza and is currently preparing for the 'first-in-human' study with LAIV for seasonal influenza. About the World Health ...

Novavax Announces Operational Status of Its Vaccine Pilot Plant and Commercial Launch Facility

... ("GMP") Pilot Plant to manufacture pandemic and seasonal influenza vaccine clinical supplies and ... readiness for pandemic influenza production, seasonal influenza vaccine and other future VLP-based ... of future pandemic results, results of our seasonal influenza vaccine or any other vaccine that we ...

Novavax CMO to Present at Phacilitate Vaccine Forum Washington 2009

... Particle (VLP) based vaccines for pandemic and seasonal influenza. Slides from the presentation will be ... manufacturing benefits of Novavax's pandemic and seasonal influenza VLP vaccines. ABOUT NOVAVAX ... of future pandemic results, results of our seasonal influenza vaccine or any other vaccine that we ...

Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial

... Rapid seasonal influenza VLP vaccine trial enrollment positions ... trial of its virus-like particle (VLP) based seasonal influenza vaccine. The Phase IIa randomized, ... and immunogenicity of different doses of its seasonal influenza VLP vaccine. Specifically, the vaccine ...

Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate

... launch of a Phase IIa study of seasonal Influenza Vaccine ROCKVILLE, Md., Sept. 16 ... trial of its virus-like particle (VLP) based seasonal influenza vaccine. The Phase IIa randomized, ... and a core matrix protein, M1. In contrast, most seasonal vaccines consist almost entirely of HA ...

Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season

... today announced the market launch of Anflu(R), a seasonal influenza vaccine, for 2008-2009 Flu ... public health implications of receiving the seasonal flu vaccine, the target population and the ... to launch Anflu(R) in China for the 2008 - 2009 seasonal influenza season. By utilizing our ...

William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals

... programs for both peramivir, our product for seasonal and life-threatening influenza, and forodesine ... BCX-4208 in psoriasis and peramivir in seasonal and life-threatening influenza. BioCryst is ... to advance development of peramivir to treat seasonal and life-threatening influenza. In February ...

Novavax Reports First Quarter 2008 Financial Results

... of 2008. -- Continued as planned to advance its seasonal influenza vaccine program through ... influenza vaccine study bode well for the seasonal program. It is important to note the safety ... be used to support the safety database for our seasonal program which will allow us to begin human ...

Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results

... hepatitis A vaccine, and Anflu(R), our seasonal influenza vaccine, based on the proactive efforts ... a promotion agreement with GSK China for our seasonal influenza vaccine, Anflu(R), and successfully ... marketing initiatives in support of the Company's seasonal influenza vaccine, Anflu(R). Gross profit for ...

LPGA Pro, Jill McGill, Encourages Indoor and Outdoor Allergy Sufferers to Challenge Their Course

... using a prescription medication to treat their seasonal allergies reported they are interested in finding ... many as 40 million people in the United States. seasonal allergic rhinitis (SAR), commonly referred to as ... By definition, SAR includes allergies to seasonal pollens like grass, trees, and weeds, as well as ...

Protherics Licenses its CoVaccine HT Adjuvant to Nobilon for Influenza Vaccine Indications

... for use in pandemic influenza vaccines, and seasonal influenza vaccines in elderly people. More than 300 million doses of seasonal influenza vaccine are produced each year ... HT(TM) adjuvant may increase the potency of a seasonal influenza vaccine for elderly people, with ...

BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza

... product candidate for the treatment of seasonal and life-threatening influenza. (Logo: ... to develop peramivir for the treatment of seasonal and life-threatening influenza. Funding from the ... and autoimmune diseases and peramivir in seasonal and life- threatening influenza. BioCryst has a ...

Revised: Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials

... reactions. Total adverse event rate is 11.8%, which is similar to that of seasonal influenza vaccine. The adverse events were all mild and transient. The ... September 2009. Consistent with prior years' practices, Sinovac's seasonal influenza vaccine was released by China SFDA and commercially launched at ...

Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials

... adverse reactions. Total adverse event rate is 11.8%, which is similar to seasonal influenza vaccine. The adverse events were all mild and transient. The ... to be delivered by the end of September. As usual, Sinovac's seasonal influenza vaccine has been released by China SFDA and officially launched ...

FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics' Focus Diagnostics Business

... influenza virus to differentiate the presence of the pandemic virus from seasonal human influenza A virus. Turnaround time for reporting results is ... this pandemic virus not faded away, it is behaving differently than the seasonal flu, which is typically absent during the summer months in the Northern ...

Sinovac Completes Construction of H1N1 Virus Seed Bank

... Production of seasonal Influenza Vaccine Is Nearly Completed BEIJING, June 15 ... of H1N1 vaccine will not affect its production and launch of the seasonal flu vaccine for this coming flu season. About Sinovac Sinovac ...

Novavax and the NIH Agree to Evaluate a Virus-like Particle (VLP) Vaccine Candidate Against the Novel Influenza A (H1N1) Virus

... illnesses to date have been of a similar severity as that of typical seasonal influenza, it is unclear if the strain will evolve to become more deadly ... results may not be predictive of future pandemic results, results of our seasonal influenza vaccine or any other vaccine that we may develop; further ...

Flu vaccine given in microneedle skin patches proves effective in mice

... skin patch method of delivering flu vaccine could improve overall seasonal vaccination coverage in people because of decreased pain, increased ... important because flu vaccine production capacity sometimes is limited for seasonal vaccine, and a future influenza pandemic would require much greater ...

Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin'

... allergies affect as many as 40 million people in the United States. seasonal allergic rhinitis (SAR), commonly referred to as "hay fever" or "outdoor ... common form of allergic rhinitis. By definition, SAR includes allergies to seasonal pollens like grass, trees, and weeds, as well as mold. Perennial Allergic ...

BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update

... has initiated a Phase 3 study of intravenous (i.v.) peramivir for seasonal influenza in the outpatient setting. Patient enrollment is underway in ... administration of i.v. peramivir 300 mg or 600 mg for the treatment of seasonal influenza in the outpatient setting. The Phase 2 study results were ...

Novavax to Present Seasonal Influenza Data Results in an Investor Conference Call on December 11, 2008

... its Phase II human clinical trial in healthy adult subjects of Novavax's seasonal influenza VLP vaccine candidate at 11:00 a.m. Eastern Time on December 11, ... results may not be predictive of future pandemic results, results of our seasonal influenza vaccine or any other vaccine that we may develop; further ...

Vical Reports Third Quarter 2008 Financial Results and Continued Progress in Product Development Programs

... same vaccine effectiveness with lower vaccine doses) with the commercial seasonal influenza and government-stockpiled H5N1 pandemic influenza vaccines. ... few months, including: -- New mouse data with Vaxfectin(R)-formulated seasonal influenza vaccines demonstrating the ability to adjust the ratio of ...

MedImmune Licenses Reverse Genetics Technology to Hungary's Omninvest for Use in Influenza Vaccine Development and Production

... licenses to these intellectual property estates for use in manufacturing seasonal or pandemic vaccines. In a first for any influenza vaccine manufacturer, MedImmune applied the reverse genetics process to the development of its seasonal live, attenuated nasal spray influenza vaccine for the 2008-2009 season. ...

BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008

... forodesine HCl in oncology, BCX-4208 in psoriasis and peramivir in seasonal and life-threatening influenza. BioCryst is collaborating with Mundipharma ... contract to BioCryst to advance development of peramivir to treat seasonal and life-threatening influenza. In February 2007, BioCryst established a ...

Roche Introduces Program to Facilitate Corporate Pandemic Stockpiling of Tamiflu(R)

... therefore be available when a pandemic begins." "Experience with seasonal flu has shown that antiviral drugs are an important tool in the arsenal of ... as recommended by the CDC. Tamiflu was approved based on studies in seasonal influenza. The magnitude of effect of Tamiflu in treating and preventing ...

BioCryst Reports First Quarter 2008 Financial Results and Clinical Update

... forodesine HCl in oncology, BCX-4208 in psoriasis and peramivir in seasonal and life-threatening influenza. BioCryst is collaborating with Mundipharma ... contract to BioCryst to advance development of peramivir to treat seasonal and life-threatening influenza. In February 2007, BioCryst established a ...

Novavax Opens Its First U.S. Vaccine Plant

... These methods should also enable the company to respond faster to seasonal or pandemic flu outbreaks once the vaccines in development are approved. ... vaccine candidates in development addressing pandemic influenza, seasonal flu, varicella zoster and an undisclosed infectious disease target. The ...

U.S. Government Accepts $192 Million of sanofi pasteur H5N1 Bulk Vaccine Antigen for Pandemic Stockpile

... facility that is expected to more than double its capacity to produce both seasonal and pandemic influenza when it begins production in early 2009. Sanofi ... preparedness. Sanofi Pasteur is investing in major expansions of its seasonal influenza vaccine production facilities in the U.S. and France, which ...

Schering-Plough/MERCK Pharmaceuticals Receives Not-Approvable Letter from FDA for Loratadine/Montelukast

... sodium), both of which are indicated for the relief of symptoms of seasonal allergic rhinitis and perennial allergic rhinitis. Schering-Plough/MERCK ... About SINGULAIR SINGULAIR is indicated for the relief of symptoms of seasonal allergic rhinitis (SAR) in adults and children two years and older, and ...

BioCryst Reports Fourth Quarter and Year End 2007 Financial Results and Corporate Update

... and commercialization of peramivir in Japan, for the treatment of both seasonal and potentially life-threatening human influenza. Shionogi initiated ... BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life- threatening influenza. BioCryst has a worldwide partnership with ...

Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage

... pasteur confirmed its leadership as the world's largest manufacturer of seasonal influenza vaccine, supplying a large portion of the estimated global ... virus. Sanofi pasteur is also investing in major expansions of its seasonal influenza vaccine production facilities in the U.S. and France, which ...